15 Best Dividend Aristocrat Stocks with Over 3% Yield

12. AbbVie Inc. (NYSE:ABBV)

Dividend Yield as of March 29: 3.2%

AbbVie Inc. (NYSE:ABBV) ranks twelfth on our list of the best dividend aristocrat stocks. The American multinational pharmaceutical company develops and brings innovative treatments to market across a wide range of healthcare sectors. Its portfolio includes treatments in immunology, eye care, oncology, and neurology. In addition, it has a strong presence in the aesthetics sector, offering cosmetic products like Juvederm and Botox for skin care and anti-aging. The stock has surged by over 14% since the start of 2025, outperforming the broader market.

AbbVie Inc. (NYSE:ABBV) reported a revenue of $15.1 billion in the fourth quarter of 2025, which showed a 5.6% growth from the same period last year. The revenue beat analysts’ expectations by $14.87 billion. The company’s net loss on a GAAP basis came in at $0.02 per share, while adjusted diluted EPS reached $2.16, slightly above the expectations of $2.13. For 2024, collective sales of Skyrizi and Rinvoq grew to $1.77 billion, up 51% on a YoY basis due to strong global demand and market expansion.

On February 13, AbbVie Inc. (NYSE:ABBV) declared a quarterly dividend of $1.64 per share, which was in line with its previous dividend. Overall, the company has been growing its payouts for 52 consecutive years. In addition, the stock offers an attractive dividend yield of 3.2%, as of March 29.

AbbVie Inc. (NYSE:ABBV) was included in 85 hedge fund portfolios at the end of Q4 2024, up from 68 in the previous quarter, as per Insider Monkey’s database. The stakes owned by these hedge funds are worth nearly $2.5 billion in total.